Terfenadine block of sodium current in canine atrial myocytes

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 3, 1999, Pages 507-513

  Lu, Yanjie ^a   Wang, Zhiguo ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Canine atrial cells; Patch clamp; Sodium current (I(Na)); Terfenadine

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST; SODIUM CHANNEL BLOCKING AGENT; SODIUM ION; TERFENADINE;

ANIMAL CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; FEMALE; HEART ATRIUM MUSCLE; HEART MUSCLE CELL; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; REVIEW; SODIUM CURRENT;

ANIMALS; ATRIAL FUNCTION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HEART ATRIA; HISTAMINE H1 ANTAGONISTS; MALE; MEMBRANE POTENTIALS; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; SODIUM CHANNELS; TERFENADINE; TIME FACTORS;

EID: 0033060988     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199903000-00023     Document Type: Review

References (33)

1. Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
2. Smith SJ. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 1994;111:348-54.
3. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6.
4. Rampe D, Wible B, Brown A, Dage R. Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993;44:1240-5.
5. Crumb J, William J, Wible B, Arnold DJ, Payne JP, Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. J Pharmacol Exp Ther 1995;47:181-90.
6. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 1995;76:110-9.
7. Yang T, Prakash C, Roden DM, Snyders DJ. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 1995;115:267-74.
8. Berul C, Morad M. Regulation of potassium channels by nonsedating antihistamines. Circulation 1995;91:2220-5.
9. Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 1996;94:817-23.
10. + channels. J Cardiovasc Pharmacol 1997;30:42-54.
11. 1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels. Eur J Pharmacol 1997;326:257-63.
12. + channels in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 1995;26:761-9.
13. 2+ channel in rat ventricular myocytes by terfenadine. Circ Res 1997;81:202-10.
14. Neyroud N, Denjoy I, Donger C, et al. Mutations in the potassium channel KvLQTl cause Jervell and Lange-Nissen syndrome. Circulation 1997;96:I-57.
15. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 1996;93:2208-12.
16. Schulze-Bahr E, Wang Q, Haverkamp W, et al. Identification of a new gene for autosomal recessive long QT syndrome (Jervell Lange-Nielsen syndrome). Circulation 1997;96:I-57.
17. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993;73:276-85.
18. Wang Q, Shen J, Li Z, et al. Cardiac sodium channel mutations in patients with long QT syndrome: an inherited cardiac arrhythmia. Hum Mol Genet 1995;4:1063-7.
19. + channel-linked long-QT syndrome. Circ Res 1996;78:916-24.
20. Hondeghem L, Katzung B. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol 1987;24:387-423.
21. Lang DG, Wang CM, Wenger TL. Terfenadine alters action potentials in isolated canine Purkinje fibres more than acrivastine. J Cardiovasc Pharmacol 1993;22:438-42.
22. Tanaka H, Masumiya H, Kato Y, Shigenobu K. Inhibitory effects of terfenadine on the rising phase of action potentials and sinus rates in isolated guinea pig myocardium. Gen Pharmacol 1996;27:337-40.
23. Ki I, Inui A, Ito T. Effects of histamine H, receptor antagonists on action potentials in guinea pig isolated papillary muscles. Arch Intern Pharmacodyn Ther 1996;331:59-73.
24. Yue L, Feng J, Gaspo R, Li G, Wang Z, Nattel S. Ionic remodeling associated with enhanced susceptibility to atrial fibrillation in a dog model. Circ Res 1997;81:512-24.
25. Wang Z, Fermini B, Nattel S. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 1994;272:184-96.
26. + current similar to Kv1.5 cloned channel currents. Circ Res 1993;73:1061-76.
27. + current. J Gen Physiol 1990;96:195-215.
28. + currents by anti-histamines in rat ventricular myocytes. Biophys J 1995;68:A113.
29. Snyders DJ, Hondeghem LM. Effects of quinidine on the sodium current of guinea pig ventricular myocytes: evidence for a drug-associated rested state with altered kinetics. Circ Res 1990;66:565-79.
30. Sanchez-Chapula J, Tsuda Y, Josephson IR. Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells. Circ Res 1983;52:557-65.
31. + channel of rabbit cardiac Purkinje fibres. Circ Res 1988;63:50-60.
32. Takafumi A, Hondeghem LM. Interactions of flecainide with guinea pig cardiac sodium channels: importance of activation unblocking to the voltase-dependence of recovery. Circ Res 1990;66:789-804.
33. Cardiac Arrhythmia Suppression Trial (CAST). Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.